Terapet is glad to announce the closing of the seed investment round of CHF 1 Million, with contribution from new investors. This funding supports the development of its first full-scale prototype to be installed for clinical validation.
Terapet SA,...Read more ›
On March 23, an initiative started amongst CERN personnel to produce 3D-printed face masks with interchangeable filters. The initial goal was to develop a 3D-printed washable mask with the possibility of fitting different types of easily-available filtration materials that would offer at least...Read more ›
CERN is actively taking part in the fight against COVID-19, identifying solutions to address societal needs and forging a path to the future post-pandemic reality. You too can benefit from the CERN know-how, while navigating to a “new normal” .
...Read more ›
The current standard for definitive diagnosis of COVID-19 is the real-time reverse transcriptase-polymerase chain reaction (RT-PCR). While this is a highly sensitive and specific test for COVID-19, it does not measure the severity nor progress of the...Read more ›
Nine years after publishing the first version of the CERN Open Hardware Licence (CERN-OHL) – which governs the use, copying, modification and distribution of hardware designs and the manufacture and...Read more ›